Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 397,274 | 278,308 | 75,462 | 102,984 | 76,479 |
| Depreciation Amortization | 226,988 | 148,957 | 72,360 | 495,439 | 373,747 |
| Income taxes - deferred | 525 | -41,236 | 509 | -125,902 | -92,723 |
| Accounts receivable | 11,971 | 20,395 | 22,603 | -78,062 | -100,545 |
| Accounts payable and accrued liabilities | -654 | -4,085 | -899 | 17,663 | 1,294 |
| Other Working Capital | -45,286 | -47,027 | 9,601 | -97,554 | -124,819 |
| Other Operating Activity | -85,958 | -100,147 | -2,336 | 206,070 | 176,866 |
| Operating Cash Flow | $504,860 | $255,165 | $177,300 | $520,638 | $310,299 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 174,238 | 174,238 | 174,238 | 70,517 | 57,390 |
| PPE Investments | -118,482 | -82,665 | -36,103 | -115,429 | -98,318 |
| Net Acquisitions | -252,546 | -252,546 | N/A | -17,635 | -17,635 |
| Purchase Of Investment | -37,109 | -1,750 | -1,750 | -113,504 | -13,366 |
| Purchase Sale Intangibles | -9,666 | -5,000 | -5,000 | N/A | N/A |
| Other Investing Activity | -9,666 | -5,000 | -5,000 | 0 | 0 |
| Investing Cash Flow | $-243,565 | $-167,723 | $131,385 | $-176,051 | $-71,929 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26,999 | 15,920 | 11,223 | 110,439 | 41,156 |
| Common Stock Repurchased | -255,451 | -215,451 | -190,451 | -85,787 | -84,787 |
| Other Financing Activity | -463,923 | -460,802 | -456,168 | -52,348 | -43,798 |
| Financing Cash Flow | $-692,375 | $-660,333 | $-635,396 | $-27,696 | $-87,429 |
| Exchange Rate Effect | 18,411 | 17,899 | 3,539 | 255 | 4,533 |
| Beginning Cash Position | 784,438 | 784,438 | 784,438 | 467,292 | 467,292 |
| End Cash Position | 371,769 | 229,446 | 461,266 | 784,438 | 622,766 |
| Net Cash Flow | $-412,669 | $-554,992 | $-323,172 | $317,146 | $155,474 |
| Free Cash Flow | |||||
| Operating Cash Flow | 504,860 | 255,165 | 177,300 | 520,638 | 310,299 |
| Capital Expenditure | -118,482 | -82,665 | -36,103 | -115,429 | -98,318 |
| Free Cash Flow | 386,378 | 172,500 | 141,197 | 405,209 | 211,981 |